| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc299202a8b5769ec9c8af124b3ac185 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D251-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D251-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 |
| filingDate |
2002-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_160d29244468c1774af356c938bdbbed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b445690382f4e9d1957b3ff79b30aa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea7a6f8eeebaac52ff3c98b8ac06712e |
| publicationDate |
2003-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6569856-B2 |
| titleOfInvention |
Selective NPY (Y5) antagonists (triazines) |
| abstract |
This invention is directed to triazine derivatives which are selective antagonists for a NPY (Y5) receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005261292-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005137240-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005176709-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005038073-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7273880-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7265109-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7189720-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004019050-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008045524-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005014593-A1 |
| priorityDate |
1999-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |